Laurel L. Ballantyne
- Co-authors
- Colin FunkXinzhi LiYing YuYuan Yan SinGarret A. FitzGeraldAlma Barajas‐EspinosaDerek A. PrattJeffrey Mewburn
- Topics
- Amino Acid Enzymes and Metabolism (4 papers)Metabolism and Genetic Disorders (4 papers)Inflammatory mediators and NSAID effects (4 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Laurel L. Ballantyne
17 papers receiving 396 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 199
- Physiology 83
- Cardiology and Cardiovascular Medicine 79
- Immunology 65
- Biochemistry 60
Countries citing papers authored by Laurel L. Ballantyne
This map shows the geographic impact of Laurel L. Ballantyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurel L. Ballantyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurel L. Ballantyne more than expected).
Fields of papers citing papers by Laurel L. Ballantyne
This network shows the impact of papers produced by Laurel L. Ballantyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurel L. Ballantyne. The network helps show where Laurel L. Ballantyne may publish in the future.
Co-authorship network of co-authors of Laurel L. Ballantyne
This figure shows the co-authorship network connecting the top 25 collaborators of Laurel L. Ballantyne. A scholar is included among the top collaborators of Laurel L. Ballantyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurel L. Ballantyne. Laurel L. Ballantyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 100 | |
| 5 | 14 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 22 | |
| 9 | 14 | |
| 10 | 12 | |
| 11 | 21 | |
| 12 | 12 | |
| 13 | 35 | |
| 14 | 35 | |
| 15 | 37 | |
| 16 | 18 | |
| 17 | 55 |
About Laurel L. Ballantyne
Laurel L. Ballantyne is a scholar working on Biochemistry, Clinical Biochemistry and Pharmacology, having authored 17 papers that have together received 400 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Biochemistry (60 citations), Clinical Biochemistry (30 citations) and Cancer Research (58 citations). Laurel L. Ballantyne has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Colin Funk, Xinzhi Li, Ying Yu, Yuan Yan Sin, Garret A. FitzGerald, Alma Barajas‐Espinosa, Derek A. Pratt, Jeffrey Mewburn, Yan Dong and Andreas Schulze. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.